Clinical trial
The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy…
NCT00254800 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00254800 |
|---|---|
| Title | The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females |
| Official title | The Effect of Exenatide on Single and Multiple Doses Oral Contraceptive Pharmacokinetics in Healthy Female Subjects |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | ethinyl estradiol and levonorgestrel, exenatide |
| Enrollment | 38 |
| Start date | Nov 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Nov 17, 2005 |
| Last update posted | Aug 18, 2015 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: